(Q43472622)

23 November 2017

0 references

1 reference

title

Advanced colorectal cancer: which regimes should we recommend? (English)

1 reference

23 November 2017

1 reference

C H Koehne

1

1 reference

23 November 2017

R Midgley

series ordinal

2

1 reference

23 November 2017

M Seymour

series ordinal

3

1 reference

23 November 2017

D J Kerr

series ordinal

4

1 reference

23 November 2017

1 August 1999

1 reference

23 November 2017

1 reference

23 November 2017

10

1 reference

23 November 2017

8

1 reference

23 November 2017

877-882

1 reference

A phase II study of weekly 24-hour infusion with high-dose fluorouracil with leucovorin in colorectal carcinoma

23 November 2017

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008348904180

7 January 2021

A prospective randomized comparison of protracted infusional 5-fluorouracil with or without weekly bolus cisplatin in metastatic colorectal carcinoma. A Mid-Atlantic Oncology Program study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008348904180

7 January 2021

Modulation of high-dose infusional fluorouracil by low-dose methotrexate in patients with advanced or metastatic colorectal cancer: final results of a randomized European Organization for Research and Treatment of Cancer Study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008348904180

7 January 2021

Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008348904180

7 January 2021

‘Tomudex’ (ZD1694): Results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008348904180

7 January 2021

Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008348904180

7 January 2021

Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008348904180

7 January 2021

Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008348904180

7 January 2021

Phase I clinical and pharmacokinetic study of leucovorin and infusional hepatic arterial fluorouracil

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008348904180

7 January 2021

Identifiers

DOI

10.1023/A:1008348904180

1 reference

23 November 2017

1 reference